Objective:
Lingzhu San (LZS) is a traditional Chinese medicine (TCM) prescription which can be effective in
treating febrile seizures (FS) and has few researches on the mechanisms. In order to better guide the clinical use of LZS, we
used the research ideas and methods of network pharmacology to find the potential core compounds, targets and pathways
of LZS in the complex TCM system for the treatment of FS, and predict the mechanism.
Materials and Methods:
Databases such as BATMAN, TCMSP, TCMID, and SWISS TARGET are used to mine the active
compounds and targets of LZS, and the target information of FS was obtained through GENECARDS and OMIM. Using
Venny2.1.0 and Cytoscape software to locked the potential core compounds and targets of FS. The R language and ClusterProfiler software package were adopt to enrich and analyze the KEGG and GO pathways of the core targets and the biological processes and potential mechanisms of the core targets were revealed.
Results:
187 active compounds and 2113 target proteins of LZS were collected. And 38 potential core compounds, 35 core
targets and 775 metabolic and functional pathways were screened which involved in mediating FS. Finally, the role of the
core compounds, targets and pivotal pathways of LZS regulated FS in the pathogenesis and therapeutic mechanism of FS
was discussed and clarified.
Conclusions:
In this paper, the multi-compounds, multi-targets and multi-pathways mechanism of LZS in the treatment of
FS was preliminarily revealed through the analysis of network pharmacology data, which is consistent with the principle of
multi-compounds compatibility of TCM prescriptions and unified treatment of diseases from multiple angles, and it provides a new way for TCM to treat complex diseases caused by multiple factors.
